PIGF and sFLT-1 appear to be the biomarkers with the highest sensitivity and specificity in predicting early-onset PE; however, these biomarkers cannot be used to predict late-onset PE or other complications of pregnancy such as IUGR or preterm birth. The gene discussed is PIGF; the disease is fetal growth restriction.